Inhalation Sciences’ new Board member brings Medtech Sales & Marketing drive, insight and experience
“The best way to get people to like and approve the product is to get them to try it out for themselves”. Meet Manoush Masarrat, ISAB’s new Board…
“The best way to get people to like and approve the product is to get them to try it out for themselves”. Meet Manoush Masarrat, ISAB’s new Board…
Inhalation Sciences’ recent announcement of a 2 MSEK order from a leading inhalation company is the third major order announced since the appointment of Lena Heffler as new…
More industrial processes than ever are using nanoparticles. Yet many questions remain about the health consequences of inhaling them. Not just in our lungs but at a cellular,…
With a major 2.4 MSEKsale, a new European patent and the upcoming installation of ISAB’s first PreciseInhale® system in China – September and October 2018 have been eventful and…
ISAB has assembled its first PreciseInhale® to Chinese standards, to be shipped to Chengdu, home of WestChina-Frontier PharmaTech (WCFP), a leading Chinese CRO drug assessment and evaluation company. Ahead…
A revelatory talk on inhaled drug assessment is one of ISAB CEO Lena Heffler’s Top Three picks from the 7th MVIC Symposium in Lund, Oct 3-4. It asked:…
The European Patent Office has granted a patent to XposeALI, ISAB’s in vitro cell culturing module. “XposeALI delivers exceptionally precise, detailed data on how airborne micro- and nanoparticles…
ISAB CEO Lena Heffler created interest at the Inhalation and Drug Respiratory Products 2018 Conference in Barcelona Sept’ 20-21. Developing respirable biologics was a hot topic—so ISAB’s precision…
Astra Zeneca researcher Jie Ji spent five years at Karolinska Institutet (KI) on advanced lung airway research using Inhalation Sciences’ technology. The project will produce a total of…
Dear Customers, Summer is arriving in Sweden and the team at Inhalation Sciences will be taking their well-deserved summer breaks at various times through July and August. We…